Suggests that ductal carcinoma in situ (DCIS) of the breast and invasive breast carcinoma
are similar if not identical. Clinical behavior; Identical genetic markers on the DCIS process …

One of the most significant developments in breast pathology in the past decade has been
the dramatic increase in the number of patients diagnosed with ductal carcinoma in situ …

Ductal carcinoma in situ (DCIS) is a neoplastic proliferation of mammary ductal epithelial
cells confined to the ductal-lobular system, and a non-obligate precursor of invasive …

Overview: Ductal carcinoma in situ (DCIS) is a heterogeneous group of diseases that differ
in biology and clinical behavior. Until 1980, DCIS represented less than 1% of all breast …

Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer where cells restricted
to the ducts exhibit an atypical phenotype. Some DCIS lesions are believed to rapidly transit …

Abstract [eng] Ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS)
represents premalignant diseases of the breast, typically localized in the milk ducts or in the …

The incidence of ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer, has
increased markedly in recent decades, and DCIS now accounts for approximately 20% of …

Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group with variable clinical
presentation. The exact molecular mechanism is not known why some ductal carcinomas …

Ductal carcinoma in situ (DCIS) is perhaps the single most contentious topic related to
breast cancer in the modern era. In the 1970s, pure DCIS was a rare entity, accounting for …

Background Ductal carcinoma in situ (DCIS) is a preinvasive lesion of the breast with an
inherent but nonobligatory tendency for progression to invasive breast cancer. Although the …